27.49
Schlusskurs vom Vortag:
$27.03
Offen:
$26.8
24-Stunden-Volumen:
591.71K
Relative Volume:
0.61
Marktkapitalisierung:
$2.18B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-36.65
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
+2.32%
1M Leistung:
+3.35%
6M Leistung:
-30.55%
1J Leistung:
+28.94%
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
VCYT
Veracyte Inc
|
27.46 | 2.18B | 399.58M | -54.04M | 40.13M | -0.75 |
![]()
TMO
Thermo Fisher Scientific Inc
|
420.73 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
201.33 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
543.34 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
120.35 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
162.23 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-20 | Eingeleitet | Craig Hallum | Buy |
2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
2024-10-16 | Eingeleitet | UBS | Buy |
2024-10-10 | Eingeleitet | Guggenheim | Buy |
2024-02-23 | Bestätigt | Needham | Buy |
2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
2022-01-07 | Eingeleitet | Stephens | Overweight |
2021-11-18 | Fortgesetzt | Goldman | Buy |
2021-06-15 | Eingeleitet | Raymond James | Outperform |
2021-02-18 | Fortgesetzt | Needham | Buy |
2021-01-28 | Eingeleitet | Truist | Buy |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
2019-07-31 | Eingeleitet | Lake Street | Buy |
2019-07-02 | Eingeleitet | Needham | Buy |
2018-11-29 | Herabstufung | Janney | Buy → Neutral |
2018-10-31 | Hochstufung | Janney | Neutral → Buy |
2017-11-07 | Herabstufung | Janney | Buy → Neutral |
2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
2017-08-31 | Fortgesetzt | BTIG Research | Buy |
2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
2015-06-11 | Bestätigt | Leerink Partners | Outperform |
2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte shareholders approve 2.5 million share increase to equity plan - Investing.com
Veracyte shareholders approve 2.5 million share increase to equity plan By Investing.com - Investing.com India
Insider Sell: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business - simplywall.st
Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability - Insider Monkey
Cathie Wood's Ark Invest Loads Up On Veracyte, Offloads 3D Systems - Benzinga
Insider Selling: John Leite Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte chief commercial officer sells shares for $76,409 By Investing.com - Investing.com Canada
Veracyte chief commercial officer sells shares for $76,409 - Investing.com Australia
Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock By Investing.com - Investing.com South Africa
Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock - Investing.com Nigeria
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Top Companies in the NASDAQ Veracyte and Others by Kalkine - Kalkine Media
Two Sigma Advisers LP Cuts Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte at Jefferies Global Healthcare Conference: Strategic Growth and Innovation - Investing.com Nigeria
Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant - Investing.com Australia
Veracyte (VCYT) Shares Pulled Back Despite Beating Expectations - MSN
Veracyte at William Blair Growth Stock Conference: Strategic Insights Unveiled - Investing.com Canada
Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - Defense World
Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO - MSN
Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research - BioSpace
Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Veracyte (VCYT) Showcases Findings at ASCO Annual Meeting | VCYT Stock News - GuruFocus
Veracyte to present multiple abstracts at ASCO - TipRanks
Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research | VCYT Stock News - GuruFocus
Veracyte Inc (VCYT) Shares Gap Down to $26.74 on May 28 - GuruFocus
Veracyte: Upgrading To Neutral (NASDAQ:VCYT) - Seeking Alpha
Captrust Financial Advisors Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Scotiabank maintains Veracyte stock with $44 target - Investing.com
Scotiabank maintains Veracyte stock with $44 target By Investing.com - Investing.com India
Deutsche Bank AG Has $3.22 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte to Participate in Upcoming Investor Conferences - 01net
Veracyte to Participate in Upcoming Investor Conferences | VCYT Stock News - GuruFocus
Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally? - Zacks Investment Research
BNP Paribas Financial Markets Sells 55,684 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
William Blair Estimates Veracyte’s Q2 Earnings (NASDAQ:VCYT) - Defense World
Stifel Financial Corp Sells 2,211 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte projects strong Decipher and Afirma growth, targets 22.5% adjusted EBITDA margin for 2025 - MSN
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veracyte Inc-Aktie (VCYT) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Bhanji Muna | Director |
Jun 13 '25 |
Sale |
26.67 |
4,589 |
122,367 |
29,989 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):